The first Sonnet BioTherapeutics Holdings trade was made in Q3 2021. Since then Jim Simons bought shares four more times and sold shares on three occasions. The investor sold all their shares in Q3 2023 and doesn't own any shares in Sonnet BioTherapeutics Holdings anymore.